Outcome in African Americans and other minorities in the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT)

American Heart Journal

Volumn 155, Issue 3, 2008, Pages 501-506

  Mitchell, Judith E ^a   Hellkamp, Anne S ^d   Mark, Daniel B ^d   Anderson, Jill ^b   Poole, Jeanne E ^c   Lee, Kerry L ^d   Bardy, Gust H ^b,c  

^a SUNY DOWNSTATE MEDICAL CENTER   (United States)

^b Seattle Institute for Cardiac Research   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMIODARONE; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; AFRICAN AMERICAN; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEFIBRILLATOR; FEMALE; HEART EJECTION FRACTION; HEART FAILURE; HEART VENTRICLE TACHYCARDIA; HUMAN; MAJOR CLINICAL STUDY; MALE; MINORITY GROUP; MORTALITY; MULTICENTER STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SUDDEN DEATH; SURVIVAL;

AFRICAN AMERICANS; AMIODARONE; ANTI-ARRHYTHMIA AGENTS; CAUSE OF DEATH; DEATH, SUDDEN, CARDIAC; ELECTRIC COUNTERSHOCK; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; MINORITY GROUPS; PROGNOSIS; SURVIVAL RATE; TIME FACTORS; UNITED STATES;

EID: 39149084747     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2007.10.022     Document Type: Article

References (17)

1. http://www.census.gov/population/www/projections/popproj.html.
2. Heiat A., Gross C.P., and Krumholz H.M. "Representation of the Elderly, Women, and Minorities in Heart Failure Clinical Trials". Arch Intern Med 162 (2002) 1682-1688
3. Yancy C.W. Heart failure in African Americans: a cardiovascular enigma. J Card Fail 6 (2000) 183-186
4. Bardy G.H., Lee K.L., Mark D.B., et al. "Amiodarone or an Implantable Cardioverter-Defibrillator for Congestive Heart Failure". N Engl J Med 352 (2005) 225-237
5. Kaplan E.L., and Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 53 (1958) 457-481
6. Cox D.R. Regression models and life-tables. J R Stat Soc [B] 34 (1972) 187-220
7. Hlatky M.A., Boineau R.E., Higginbotham M.B., et al. A brief self-administered questionnaire to determine functional cpacity (the Duke Activity Status Index). AJC 64 (1989) 651-654
8. Strey C.H., Young J.M., Lainchbury J.H., et al. Short-term statin therapy improves endothelial function and neurohormonal imbalance in normocholesteraemic patients with non-ischaemic heart failure. BMJ 92 (2006) 1603-1609
9. Ip J.H., Dickinson G., Olshansky B., et al. Does statin therapy decrease mortality in patients with cardiomyopathy? Unanticipated observations from SCDHeFT. Circulation 112 (2005) 11-382
10. Ahmed A., Rich M.W., Love T.E., et al. Digoxin and reduction in mortality and hospitalization in heart failure: a comprehensive post hoc analysis of the DIG trial. Eur Heart J 27 (2006) 178-186
11. Vorobiof G., Goldenberg I., Moss A.J., et al. Effectiveness of The Implantable Cardioverter Defibrillator in Blacks Versus Whites (from MADIT-II). AJC 98 (2006) 1383-1386
12. Kadish A., Dyer A., Daubert J.P., et al., for the Defibrillators in Non-Ischemic Cardiomyopathy Treatment Evaluation (DEFINITE) Investigators. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med 350 (2004) 2151-2158
13. Russo A.M., Hafley G.E., Lee K.L., and Stamato N.J. Lehmann MH et al. "Racial Differences in Outcome in the Multicenter UnSustained Tachycardia Trial (MUSTT)-A Comparison of Whites vs. Blacks". Circulation 108 (2003) 67-72
14. Gauri A.J., Davis A., Hong T., Burke M.C., and Knight B.P. Disparities in the use of primary prevention and defibrillator therapy among blacks and women. Am J Med 119 (2006) 167
15. Groeneveld P.W., Heidenreich P.A., and Garber A.M. Trends in implantable cardioverter-defibrillator racial disparity: the importance of geography. J Am Coll Cardiol 45 (2005) 72-78
16. Voigt A., Ezzeddine R., Barrington W., et al. Utilization of implantable cardioverter-defibrillators in survivors of cardiac Arrest in the United States from 1996 to 2001. JACC 44 (2004) 855-858
17. Alexander M., Baker L., Clark C., et al. "Management of Ventricular Arrhythmias in Diverse Populations in California". Am Heart J 144 (2002) 431-439